The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: oxaliplatin     Quarter: 2016Q3

Total Records: 864     Number of Pages: 44

DRUGNAME PT EventCount
OXALIPLATIN. Large intestine perforation 1
OXALIPLATIN. Laryngeal oedema 1
OXALIPLATIN. Leukocytosis 1
OXALIPLATIN. Leukoencephalopathy 1
OXALIPLATIN. Liver disorder 1
OXALIPLATIN. Lung disorder 1
OXALIPLATIN. Lung neoplasm 1
OXALIPLATIN. Lymph node calcification 1
OXALIPLATIN. Lymphopenia 1
OXALIPLATIN. Metastases to lung 1
OXALIPLATIN. Multiple organ dysfunction syndrome 1
OXALIPLATIN. Multiple-drug resistance 1
OXALIPLATIN. Muscular weakness 1
OXALIPLATIN. Myelodysplastic syndrome 1
OXALIPLATIN. Nasal dryness 1
OXALIPLATIN. Nasal mucosal ulcer 1
OXALIPLATIN. Neoplasm 1
OXALIPLATIN. Nerve injury 1
OXALIPLATIN. Nodular regenerative hyperplasia 1
OXALIPLATIN. Nodule 1

Total Records: 864     Number of Pages: 44